Is Immune Checkpoint Inhibition Part of Standard Therapy for Stage III Non-Small Cell Lung Cancer?

被引：0
|
作者：
Patel, Jyoti D. [1 ]
Chmura, Steven J. [2 ]
机构：
[1] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Radiat Oncol, Chicago, IL 60637 USA
来源：
CANCER | 2018年 / 124卷 / 14期
关键词：
RANDOMIZED PHASE-III; CONSOLIDATION; RADIOTHERAPY; CONCURRENT; TRIAL; PEMBROLIZUMAB; CISPLATIN; RADIATION; DOCETAXEL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2878 / 2880
页数：3
相关论文
共 50 条
  • [1] Immune checkpoint inhibition in early-stage non-small cell lung cancer
    Cuppens, Kristof
    Du Pont, Bert
    Knegjens, Joost
    Maes, Brigitte
    Baas, Paul
    [J]. LUNG CANCER, 2024, 193
  • [2] Immune Checkpoint Therapy in Non-Small Cell Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    [J]. CANCER JOURNAL, 2016, 22 (02): : 81 - 91
  • [3] Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer
    Jiang, Jiehan
    Jin, Zheng
    Zhang, Yiqun
    Peng, Ling
    Zhang, Yue
    Zhu, Zhiruo
    Wang, Yaohui
    Tong, De
    Yang, Yining
    Wang, Jianfei
    Yang, Yadong
    Xiao, Kui
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Reflections on immune checkpoint inhibition in non-small cell lung cancer
    Leventakos, Konstantinos
    Mansfield, Aaron S.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 411 - 413
  • [5] Robust prediction of immune checkpoint inhibition therapy for non-small cell lung cancer.
    Zhang, Yiqun
    Zhao, Guodong
    He, Ning
    Wang, Lingyu
    Wang, Jianfei
    Jin, Ge
    Lin, Rongbo
    Yang, Yadong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer
    Melosky, Barbara
    Juergens, Rosalyn
    McLeod, Deanna
    Leighl, Natasha
    Brade, Anthony
    Card, Paul B.
    Chu, Quincy
    [J]. LUNG CANCER, 2019, 134 : 259 - 267
  • [7] Optimizing current standard of care therapy for stage III non-small cell lung cancer
    Verma, Vivek
    Lin, Steven H.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2033 - 2039
  • [8] Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC)
    Bodor, J. Nicholas
    Boumber, Yanis
    Borghaei, Hossein
    [J]. CANCER, 2020, 126 (02) : 260 - 270
  • [9] Immune checkpoint inhibitors in early-stage non-small cell lung cancer: New standard of care?
    Vidal, C. Martin
    Samtani, Suraj
    [J]. REVISTA MEDICA CLINICA LAS CONDES, 2024, 35 (02): : 74 - 81
  • [10] Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Soh, Junichi
    Hamada, Akira
    Fujino, Toshio
    Mitsudomi, Tetsuya
    [J]. CANCERS, 2021, 13 (16)
12345